All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What are the options for cell-based therapies in mantle cell lymphoma?

During the Virtual 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the Lymphoma Hub spoke to Mehdi Hamadani, Medical College of Wisconsin, Milwaukee, US. We asked, What are the options for cell-based therapies in mantle cell lymphoma?

What are the options for cell-based therapies in mantle cell lymphoma?

In this video, Hamadani gives an overview of the three main cell-based therapy options for mantle cell lymphoma: autologous hematopoietic stem cell transplantation, allogeneic transplantation, and in more recent years, chimeric antigen receptor (CAR) T-cell therapies. Hamadani believes it is an exciting time for the treatment and management of mantle cell lymphoma, with an increasing number of cellular therapy options becoming available.

Share: